Click HERE to view Webcast
This educational program is specifically designed for hematologists, oncologists, internists and other physicians, physicians-in-training, and healthcare professionals (nurses and pharmacists) involved in and/or interested in lymphoma, myeloma, and related plasma cell disorders and their management. No specialized knowledge or skill other than general familiarity with hematology or internal medicine is required for successful participation in this program.
Several nationally renowned experts in hematology illuminate emerging data as it affects therapy options in the treatment of chronic lymphocytic leukemia, multiple myeloma, and non-Hodgkin lymphoma in this timely Webcast. This educational offering is taken directly from a symposium titled “Immunomodulatory Therapy in the Management of Hematologic Malignancies” held the 2007 Lymphoma & Myeloma meeting in New York City in October 2007.
After completing this activity, the participant will be able to:
- Assess the emerging role of immunomodulatory agents in the treatment of multiple myeloma, chronic lymphocytic leukemia, and non-Hodgkin lymphoma
- Interpret recent results with the use of immunomodulatory agents for the treatment of hematologic malignancies
- Identify future directions with the use of immunomodulatory agents in hematologic malignancies
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), Imedex®, LLC must ensure balance, objectivity, independence, and scientific rigor in its educational activities. Faculty are encouraged to provide a balanced view of therapeutic options by utilizing generic names of several to ensure impartiality.
All faculty participating in an Imedex activity are required to disclose commitments to and/or relationships with pharmaceutical companies, biomedical device manufacturers or distributors, or others whose products or services may be considered to be related to the subject matter of the educational activity. Disclosure of these commitments and/or relationships is included in these course materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations.
The following indicates the faculty disclosure declaration information and the nature of those commercial relationships.
1=grant/research support 2=consultant 3=speaker’s bureau 4=stock shareholder 5=other support
| Alessandra Ferrajoli, MD |
Bayer HealthCare Corporation1 |
| John P. Leonard, MD |
Biogen Idec Inc2,3; Cephalon Corporation1,2; GlaxoSmithKline1,2,3; Millennium Pharmaceuticals, Inc.2,3 |
| Sagar Lonial, MD |
Millennium Pharmaceuticals, Inc.1,2 |
| Ruben Niesvizky, MD |
Millennium Pharmaceuticals, Inc.3; Novartis Pharmaceuticals Corporation3; Ortho Biotech Products, L.P.3 |
The following speakers have reported an affiliation with the supporter of this symposium:
| Alessandra Ferrajoli, MD |
Celgene Corporation1,3 |
| John P. Leonard, MD |
Celgene Corporation 2 |
| Sagar Lonial, MD |
Celgene Corporation 2 |
| Ruben Niesvizky, MD |
Celgene Corporation 3 |
All materials are included with the permission of the authors.
All Imedex staff members who are in a position to control the content of this activity have no financial relationships with any commercial interests that are relevant to this activity.
This activity is sponsored by Imedex, LLC.
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
In order to receive credit, participants must successfully complete the post-test and complete the online evaluation form. You will receive an online CME statement of credit to print for your records.
For questions regarding the accreditation of this activity, please contact
Imedex
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751-7334
Email: enduring@imedex.com
This Webcast may contain information about experimental and other uses of drugs or devices that are not currently approved by the US Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. Participants from other countries should consult with their respective regulatory authorities.
The opinions expressed in this email case discussion are the opinions of the authors and do not necessarily reflect the opinions of Imedex, LLC.
The following company has provided an unrestricted educational grant in support of this activity: Celgene Corporation.
Click HERE to view Webcast
| System Requirements: |
 is required for proper viewing. Click here to download
- Pentium 500 processor or greater
- Windows 98/NT/2000/XP or Mac OS 9/X
- Microsoft Internet Explorer 5.5 or later
(Firefox browser currently not supported)
- 128 MB of RAM
- Monitor settings: High color at 800 x 600 pixels
- Sound card and speakers
Audio troubleshooting
For general troubleshooting concerning audio or video playback issues consult the following Web link: http://support.microsoft.com/kb/306317.
|
|
